Cannabidiol (CBD) is fast emerging as an exciting ingredient across the pharmaceutical market, powered by increasing scientific research investigating its potential benefits in a number of disease states, including central nervous system (CNS) disorders, pain management, cancer and more. While there is a remarkable opportunity for the development of CBD-based solutions in the field, formulation can be challenging at times, especially when the focus is on increasing the oral bioavailability of the molecule. There are new and emerging ways to address the technical challenges associated with CBD bioavailability and enable the molecule to fulfill its full potential as a therapeutic agent. Here, we explore how lipid-based systems may hold the key to success in this space.
Understanding the complexity of CBD f…